Organization
InterveXion Therapeutics
3 clinical trials
Clinical trial
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single-Dose Intravenous Study to Evaluate the Safety and Pharmacokinetics of IXT-m200 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-03-18
Clinical trial
Meth-OD: A Phase 2a Study of IXT-m200 in Patients With Toxicity From Methamphetamine OverdoseStatus: Terminated, Estimated PCD: 2022-10-05